Search Send This Page Contact Us
Donate!
Get E-News
Get Involved
About The Foundation
Disorders
Treatment
Research
Calendar
Patient Forum
Monthly E-News
Donate!
International
Home
 

 

SPF Research Awards  2008   2007    2006    2005   2004   2003

New - Click here for information on PDA Clinical Trial

SPF Grant Summary (thanks to Thurza Campbell)

The Spastic Paraplegia Foundation is dedicated to advancing research and ultimately finding the cures for two closely related groups of neurodegenerative disorders termed Hereditary Spastic Paraplegia and Primary Lateral Sclerosis. These conditions share the common pathologic feature of degeneration principally of the upper motor neurons. 

The impetus for forming the Foundation was inspired by the accelerating pace of research on these conditions. Dramatic breakthroughs have been made in the past decade, catapulting these conditions from being poorly understood to being on the threshold of significant treatment and cures.

Scientists have unraveled many of the riddles regarding the complicated biochemistry of these diseases. Many HSP genes have now been discovered as well as a gene for PLS. Animal models for these disorders are underway. These will enable investigators to uncover the biochemical processes that cause nerve degeneration and identify and test therapy targets. Please visit Publications to review recent HSP and PLS research studies.

An increased focus on our diseases is timely and critical. There is indeed reason to hope for treatments and therapies in coming years that will restore significant function to people affected by SPF diseases. And, uncovering more of these riddles may also lead to important findings for related conditions such as ALS, spinal cord injury and Alzheimer's Disease. Researchers say common threads link the many neurologic conditions that affect millions of people.

Fostering communication and collaboration between researchers, improving their access to data and providing direction to their efforts will accelerate the pace towards finding the cures for many diseases. The SPF will support new initiatives, take smart risks and make sure research dollars are spent wisely.

The Spastic Paraplegia Foundation is a volunteer managed and driven, publicly supported organization. Make a contribution to research or discuss ways your company can become a partner.

PDA Clinical Trial

Pseudobulbar affect (PBA) impacts more than 1 million people in the United States diagnosed with neurologic disease or brain injury, such as multiple sclerosis (MS), amyotrophic lateral sclerosis also known as Lou Gehrig's disease (ALS), Parkinson's disease, dementias including Alzheimer's disease, stroke, and traumatic brain injury.

If you or someone you know experiences episodes of uncontrollable laughing and/or crying, you may be eligible to participate in a clinical study now underway to find a treatment for pseudobulbar affect (PBA).  Click here if you are interested or would like more information.

PLS and HSP genes discovered thus far:

PLS genes:

  • ALSin (also see ALSin HSP gene below)

HSP genes (32 genetic types have been defined with 14 genes discovered to date)

Article by John K. Fink, M.D.: The Hereditary Spastic Paraplegias - Nine Genes and Counting

(five more genes have been discovered since that article was published)

Recommended Links:

 

Upcoming SPF Connections
Fishkill, NY - May 10
Hartford, CT - June 4
Philadelphia - June 6-7
Mayfield, KY - July 21
Georgia - Aug 8-10
Let us know about your event

Other events
Abilities Expo
Movement for Living Seminars
Support Group Meetings
 

Visit Calendar for details

Synapse
On-line Newsletter

Helpful Links
Shared by our community

Email Support Groups
Meet, share, learn

Calendar
Upcoming events

Connections Events
Past events/photos

Support Research
When you shop online!

Worldwide Database
Join and find others

 

design by the editors
last updated 02/09/2008
  © 2003 Spastic Paraplegia Foundation, Inc.
Privacy Statement/Legal Notice